标题
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 6, Pages 1803
出版商
MDPI AG
发表日期
2018-06-19
DOI
10.3390/ijms19061803
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- Resistance to immunotherapy: clouds in a bright sky
- (2017) Gérard Milano INVESTIGATIONAL NEW DRUGS
- The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production
- (2017) Colleen S. Netherby et al. JOURNAL OF IMMUNOLOGY
- Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology
- (2017) Antonio Sica et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs
- (2017) Haejung Won et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Energy metabolic pathways control the fate and function of myeloid immune cells
- (2017) Amir A. Al-Khami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
- (2017) W. K. Eddie Ip et al. SCIENCE
- Inflammation by way of macrophage metabolism
- (2017) Agnieszka M. Kabat et al. SCIENCE
- STAT3 Regulation of Citrate Synthase Is Essential during the Initiation of Lymphocyte Cell Growth
- (2017) Sarah MacPherson et al. Cell Reports
- Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
- (2016) Q. Zhang et al. BLOOD
- STAT3 signaling in immunity
- (2016) Emily J. Hillmer et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
- (2016) Vinit Kumar et al. IMMUNITY
- The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
- (2016) Tsuyoshi Shirai et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Metabolism Is Central to Tolerogenic Dendritic Cell Function
- (2016) Wen Jing Sim et al. MEDIATORS OF INFLAMMATION
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells
- (2016) Haiyan S. Li et al. Science Signaling
- Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
- (2016) Katrin Moses et al. SEMINARS IN IMMUNOLOGY
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells
- (2016) Haiyan S. Li et al. Science Signaling
- STAT3: too much may be worse than not enough!
- (2015) E. Haddad BLOOD
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- (2015) D. M. S. Hossain et al. CLINICAL CANCER RESEARCH
- STAT3 the oncogene - still eluding therapy?
- (2015) Matthew S. Wake et al. FEBS Journal
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Pazopanib as Third Line Therapy for Metastatic Renal Cell Carcinoma: Clinical Efficacy and Temporal Analysis of Cytokine Profile
- (2015) Sumanta Kumar Pal et al. JOURNAL OF UROLOGY
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- STAT3 regulated ARF expression suppresses prostate cancer metastasis
- (2015) Jan Pencik et al. Nature Communications
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
- (2015) Sarah K. Maenhout et al. Oncotarget
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
- (2014) W. Cao et al. JOURNAL OF IMMUNOLOGY
- Setback for JAK2 inhibitors
- (2014) Mark Ratner NATURE BIOTECHNOLOGY
- TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation
- (2014) Bart Everts et al. NATURE IMMUNOLOGY
- Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
- (2014) S. Saeed et al. SCIENCE
- Tumor-Induced STAT3 Signaling in Myeloid Cells Impairs Dendritic Cell Generation by Decreasing PKC II Abundance
- (2014) M. R. Farren et al. Science Signaling
- Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
- (2013) D. M. S. Hossain et al. BLOOD
- TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
- (2013) C. Gao et al. CANCER RESEARCH
- Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
- (2013) Jeremy D. Waight et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of myelodysplasia by myeloid-derived suppressor cells
- (2013) Xianghong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development
- (2012) H. S. Li et al. BLOOD
- Immunotherapy earns its spot in the ranks of cancer therapy
- (2012) Drew Pardoll et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways
- (2012) Peter J Murray et al. NATURE IMMUNOLOGY
- Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
- (2012) Jian Yang et al. STEM CELLS
- A Requirement of STAT3 DNA Binding Precludes Th-1 Immunostimulatory Gene Expression by NF- B in Tumors
- (2011) H. Lee et al. CANCER RESEARCH
- Paucity of genotype–phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)
- (2011) Jennifer Heimall et al. CLINICAL IMMUNOLOGY
- A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory
- (2011) Andrea M. Siegel et al. IMMUNITY
- An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
- (2011) Weiguo Cui et al. IMMUNITY
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells
- (2011) Masako Saito et al. JOURNAL OF EXPERIMENTAL MEDICINE
- S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression
- (2011) M. Ichikawa et al. MOLECULAR CANCER RESEARCH
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
- (2010) C. M. Krawczyk et al. BLOOD
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function
- (2010) Jessica A. Melillo et al. JOURNAL OF IMMUNOLOGY
- A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN- -induced MHC class II molecule on primary human blood macrophages
- (2010) L. L. Y. Chan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Toll-like Receptor and RIG-1-like Receptor Signaling
- (2009) Taro Kawai et al. Annals of the New York Academy of Sciences
- Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
- (2009) Marcin Kortylewski et al. CANCER CELL
- Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
- (2009) M. Kortylewski et al. CANCER RESEARCH
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
- (2008) N. de la Iglesia et al. GENES & DEVELOPMENT
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway
- (2008) S. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started